Alaunos Therapeutics, Inc.
For the period ended Oct 13, 2026. Filed Oct 13, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 13, 2026 · Filed Oct 13, 2026
Use the contents to explore the available documents and sections.
TCRT$1.74-5.4%Stored close · as of Nov 6, 2026
Contents
Indemnification Agreements
In connection with Mr. Harwin’s appointment as a director, the Company expects to enter into its standard form of indemnification agreement for directors with Mr. Harwin.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.